Jennifer Larson | executive |
Steven Hoerter | executive |
Matthew Sherman | executive |
Daniel Martin | executive |
Margarida Duarte | executive |
Thomas Kelly | executive |
Jessica Fye | analyst |
Tyler Van Buren | analyst |
Eun Yang | analyst |
Michael Schmidt | analyst |
Christopher Raymond | analyst |
Bradley Canino | analyst |
Reni Benjamin | analyst |
Peter Lawson | analyst |
Good morning, everyone, and welcome to Deciphera Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call.
Today's call is being recorded. At this time, I would like to turn the call over to Jen Larson, Senior Vice President of Finance and Investor Relations. Jen?
Thank you, operator.